Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Cybin Inc (CLXPF)

Cybin Inc (CLXPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Psychedelics Could Positively Impact the $2.5 Trillion Mental Health Market BayStreet.ca - Wed Mar 23, 2022

Psychedelics could soon revolutionize the $2.5 trillion mental health market. In fact, according to co-CEO of the ATMA Journey Centers, David Harder, a quoted in a company press release, “The surge...

CYBN : 0.3550 (-1.50%)
CLXPF : 3.0200 (-1.31%)
FTRP.TO : 1.09 (+5.83%)
FTRP : 4.2105 (+1.07%)
MCUR.CN : 0.075 (+36.36%)
MCURF : 0.5070 (+148.53%)
ATAI : 1.9700 (+5.35%)
NEON.CN : 0.300 (unch)
NMDBF : 0.0076 (+11.76%)
Psychedelics Could Alter a Potential $2.5 Trillion Mental Health Market Baystreet - Tue Sep 28, 2021

Psychedelics could soon revolutionize the $2.5 trillion mental health market. In fact, according to ...

CYBN : 0.3550 (-1.50%)
CLXPF : 3.0200 (-1.31%)
FTRP.TO : 1.09 (+5.83%)
FTRP : 4.2105 (+1.07%)
MCURF : 0.5070 (+148.53%)
ATAI : 1.9700 (+5.35%)
NMDBF : 0.0076 (+11.76%)
FTRP.CN : 5.550 (+1.46%)
MCUR.CN : 0.075 (+36.36%)
NEON.CN : 0.300 (unch)
Cybin to Commence Trading on the NYSE American on August 5 Business Wire - Wed Aug 4, 2021

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its common shares will open...

CYBN.NE : 0.4850 (-1.02%)
CLXPF : 3.0200 (-1.31%)
Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5 Business Wire - Wed Jul 28, 2021

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has received approval for...

CYBN.NE : 0.4850 (-1.02%)
CLXPF : 3.0200 (-1.31%)
Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares Business Wire - Wed Jul 28, 2021

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, announced today the pricing of its previously announced...

CYBN.NE : 0.4850 (-1.02%)
CYBN : 0.3550 (-1.50%)
CLXPF : 3.0200 (-1.31%)
Cybin Announces Conditional Listing Approval from NYSE American Business Wire - Wed Jul 21, 2021

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has received conditional...

CYBN.NE : 0.4850 (-1.02%)
CLXPF : 3.0200 (-1.31%)
Cybin Files its 13th Patent Application and Announces Digital Therapeutics Strategy Business Wire - Tue Jul 13, 2021

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has filed its 13th new provisional...

CYBN.NE : 0.4850 (-1.02%)
CLXPF : 3.0200 (-1.31%)
Cybin to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit on July 13th Business Wire - Fri Jul 9, 2021

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that Doug Drysdale, Chief Executive...

CYBN.NE : 0.4850 (-1.02%)
CLXPF : 3.0200 (-1.31%)
Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio Business Wire - Thu Jul 8, 2021

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today announced the scaling up of its European operations...

CYBN.NE : 0.4850 (-1.02%)
CLXPF : 3.0200 (-1.31%)
Rising Prevalence of Mental Depression & Anxiety Major Drivers Propelling Demand In Psychedelic Drugs Market FinancialNewsMedia - Wed Jul 7, 2021

Palm Beach, FL – July 7, 2021 – Psychedelic drugs and therapies are truly becoming mainstream and are expected to become even more so in the years to come. Psychedelic drugs involve various types of...

CYBN.NE : 0.4850 (-1.02%)
OPTI.CN : 0.3000 (-9.09%)
OPTHF : 0.2200 (-6.38%)
MNMD : 8.87 (+2.19%)
CMPS : 8.25 (-1.32%)
ATAI : 1.9700 (+5.35%)
CLXPF : 3.0200 (-1.31%)
CYBN : 0.3550 (-1.50%)
GTMS.TO : 0.97 (-15.65%)
GBNH : 0.1210 (-40.69%)

Barchart Exclusives

Should You Buy This Beaten-Down AI Stock for Its 4% Dividend Yield? Barchart - Tue Apr 23, 6:30PM CDT
Sales of AI-enabled gadgets are expected to drive hardware sales over the next few years. PC maker HP looks like an AI play worth buying for its nearly 4% dividend yield and tepid valuations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot